According to the National Poll on Healthy Aging, nearly 60% of older adults with obesity were interested in a weight management drug. Over three-fourths of surveyed seniors thought Medicare should ...
Major employers and insurance companies are eliminating coverage for GLP-1 weight-loss drugs. Louisiana families now must choose between $1,000+ monthly payments or stopping treatment.
(MENAFN- GlobeNewsWire - Nasdaq) - Participants in the combined treatment group lost significantly more weight at 3, 6, and 12 months and were more likely to lose 5%, 10%, or >15% of their body weight ...
The FDA is requesting that drugmakers remove suicidal ideation and behavior warnings from the labeling of three GLP-1 receptor agonists — Saxenda (liraglutide), Wegovy (semaglutide) and Zepbound ...
Regulator asks drugmakers to remove warnings of suicidal thoughts from GLP-1 drugs' labels FDA finds no link between GLP-1 drugs and suicidal thoughts Novo Nordisk and Eli Lilly welcome FDA's ...
The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and ...
- Participants in the combined treatment group lost significantly more weight at 3, 6, and 12 months and were more likely to lose 5%, 10%, or >15% of their body weight at 12 months compared with DELI ...
Los Angeles, California, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and isn't medical advice. Always consult a qualified healthcare professional ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has requested mention of risk for suicidal ...
The FDA requested that manufacturers of GLP-1 receptor agonists (RAs) remove the warning regarding the risk of suicidal ideation and behavior (SI/B) from the drugs’ labeling. In July 2023, after ...
FDA Moves to Remove Suicide Warnings From GLP-1 Weight Loss Drugs THURSDAY, Jan. 15, 2026 (HealthDay News) — Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results